News Detail

Mumbai, 23 Nov 2022: The Indian Pharmacopoeia Commission (IPC) has rejected Central Drugs Standard Control Organisation (CDSCO)’s request for extension of timelines to implement Indian Pharmacopoeia (IP) 2022.
Drugs Controller General of India (DCGI) Dr VG Somani......
View Details
Source : Pharmabiz
Indian Pharmacopoeia Commission
IPC
CDSCO
Indian Pharmacopoeia
IP 2022
DCGI
phytopharmaceutical ingredient
Related News
- US FDA approves at-home artificial insemination kit for first time (07-12-2023)
- KMCH Transfusion Center activates MM Assay for safe transfusions (07-12-2023)
- 1140 Bottles of banned intoxicant cough syrup seized by Gharghoda Police, one arrested (07-12-2023)
- New drug law to be introduced in Parliament (07-12-2023)
- 67,000 patients became addicted to Buprenorphine in Punjab (07-12-2023)
- Stevia can't be used in cocoa & chocolate products and imitation chocolate: FSSAI (07-12-2023)
- Gujarat: Death Toll reaches seven in Kheda, Mumbai supplier arrested, Supplied 13,000 Litres of base solvent (07-12-2023)
- One arrested with 16 Buprenorphine Injs in Panipat and another with 28 Injs at Ambala (07-12-2023)
- 20,000 Yaba Tablets seized in Tripura near Bangladesh border by Assam Rifles (07-12-2023)
- NCH notifies regulations for medical research in Homoeopathy (07-12-2023)